英文別名 | Coenzyme Q9;Ubiquinone Q9;Ubidecarenone Related Compound A;2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]cyclohexa-2,5-diene-1,4-dione;4-HYDROXY ALVERINE-D5;2,3-dimethoxy-5-methyl-2-<(all-e)-3',7',11',15',19',23',27',31',35'-nonamethylhexatriaconta-2',6',10',14',18',22',26',30',34',nonaenyl>cyclohexa-2,5-dien-1,4-dion;All-Trans Coenzyme Q9;Coenzyme Q(sub 9);Coenzyme?Q9;CoQ9;Q-9 Ubiquinone-45 Ubiquinone-9;Ubiqui;Ubiquinone 9;Q-9;Ubiquinone-45;Ubiquinone-9;Coenzyme Q9;NSC 226993;Ubiquinone 45;p-Benzoquinone,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-;coenzyme-Q9;Q27102857;CoQ(sub 9);(all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexadiene-1,4-dione;UNII-MGW7TYF2DQ;ubiquinone(9);2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]cyclohexa-2,5-diene-1,4-dione;Ubidecarenone impurity D, European Pharmacopoeia (EP) Reference Standard;2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-E)-;MFCD00056635;J-017946;DTXSID601317880;2,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-E)-;1ST158298;AKOS027307694;Ubiquinone9;303-97-9;C01967;Ubiquinone Q9;CoQ9;Ubiquinone 9;AS-77794;LMPR02010004;Coenzyme Q(9);CS-6359;Coenzyme Q9, >=96.0% (HPLC);HY-101415;MGW7TYF2DQ;UBIQUINONE Q9 (STN);CHEMBL2252965;COENZYMEQ9;2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)-;p-Benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-;NSC226993;BRN 1900081;2-methyl-3-nonaprenyl-5,6-dimethoxy-1,4-benzoquinone;2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]-1,4-benzoquinone;Ubiquinone Q(sub 9);NSC-226993;4-08-00-03313 (Beilstein Handbook Reference);UBIDECARENONE IMPURITY D [EP IMPURITY];p-Benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)- (VAN);CHEBI:18160;Ubidecarenone impurity D;Coenzyme Q9?;2,3-Dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)-1,4-benzoquinone;2,3-Dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1... |
---|